Search the Archive

Medicine: Obesity / Dexfenfluramine #162758

ABC Evening News for Monday, Jan 29, 1996
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Peter Jennings) Report introduced.

(New York: John McKenzie) Scientific research on the anti-obesity drug known as dexfenfluramine that suppresses the overeating of carbohydrates examined; animation shown to illustrate how the drug fools the brain. [MIT neuroscientist Dr. Richard WORKMAN - explains how the drug works.] [London Guy's Hospital Dr. Nick FINER - cites the effect of the drug already on the market in Europe.] [Rockefeller University Dr. Jules HIRSCH - downplays the drug's importance and wonders about its long-term side effects.]

(Studio: Peter Jennings) Drug manufacturer American Home Products said planning an aggressive campaign if government approval is granted.

Jennings, Peter;
McKenzie, John

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.